Sign in

    Steve Perry

    Research Analyst at Airco Industries

    Steve Perry is an analyst at Airco Industries specializing in industrial manufacturing and supply chain analytics, where he provides detailed coverage of companies in the HVAC, plastics, and advanced materials sectors. Within his role, Perry has analyzed firms such as Trane Technologies, Owens Corning, and BASF, demonstrating a strong track record in performance with portfolio recommendations achieving an average annualized return above industry norms and consistently ranking in the top quartile of analyst rankings on leading platforms. He began his career in financial analysis in the early 2000s, holding positions at regional consulting firms before joining Airco Industries in 2017, where he quickly advanced to a senior analyst position. Perry maintains active FINRA registration with Series 7 and Series 63 securities licenses and is regularly recognized for his contributions in supply chain optimization and risk analysis.

    Steve Perry's questions to CollPlant Biotechnologies (CLGN) leadership

    Steve Perry's questions to CollPlant Biotechnologies (CLGN) leadership • Q2 2023

    Question

    The analyst asked about the timing and commercialization timeline for the dermal filler product, the size of the dermal filler market, and AbbVie/Allergan's potential market strategy for the new product.

    Answer

    The company cannot disclose specific timelines for the dermal filler program as it is led by their partner, AbbVie. They confirmed the program is in the clinical phase, has been in development for about 4 years, and is progressing as planned. They cited the current dermal filler market size as $5.5 billion with 10% annual growth. They could not comment on AbbVie's future market strategy for the product.

    Ask Fintool Equity Research AI